NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Flomics Biotech

Flomics Biotech

Private
BarcelonaHealthcare & Life Scienceshttps://www.flomics.com/

Last Round

Crowdfunding

Jul 12, 2024

Est. Valuation

$10.67M

Total Funding Raised

$3.18M

Company Overview

Flomics Biotech is a biotechnology company that develops liquid biopsy tests for the early detection of cancer and other complex diseases using cell-free RNA and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

liquid biopsycell-free RNAcfRNAcancer blood testearly cancer detectionNGSnext-generation sequencingbioinformaticsprecision medicinediagnostic screeningbiomarker discoverymedical AICROcontract research organizationoncology diagnosticsmulti-cancer screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Flomics Biotech Comparables

Compare Flomics Biotech with similar companies based on industry and business-model similarity.

Flomics Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MultiplAI Health
77%
Elypta
77%
ExBiome B.V.
76%

Flomics Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJul 12, 2024
SeedMar 6, 2024
SeedMar 31, 2022

Key People

Founding team and executive leadership

André Guedes

COO & Co-founder

Founding Team

João Curado

Co-Founder and CEO

Founding Team

Flomics Biotech Investors

Notable investors and investment history

Flomics Biotech investors
InvestorRounds
Decelera VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 14, 2026

    Grew 25% QoQ, from 16 to 20 employees.

Flomics Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Flomics Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Flomics Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range21
Year Founded2018
Last FundingJul 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.